Immunogenicity of SA 14-14-2 JE Vaccine

NCT01635816 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1000

Enrollment

OTHER

Sponsor class

Conditions

Healthy Infants

Interventions

BIOLOGICAL: JE Vaccine existing facility
BIOLOGICAL: JE vaccine new plant lot 1
BIOLOGICAL: JE vaccine new plant lot 2
BIOLOGICAL: JE vaccine new plant lot 3

Sponsor

International Centre for Diarrhoeal Disease Research, Bangladesh